Double-blind comparison of placebo and 42-548, a new appetite suppressant, in obese volunteers.
作者信息
De Felice E A, Bronstein S, Cohen A
出版信息
Curr Ther Res Clin Exp. 1969 May;11(5):256-62.
PMID:4977396
Abstract
摘要
相似文献
1
Double-blind comparison of placebo and 42-548, a new appetite suppressant, in obese volunteers.安慰剂与新型食欲抑制剂42 - 548在肥胖志愿者中的双盲对照研究。
Curr Ther Res Clin Exp. 1969 May;11(5):256-62.
2
Controlled clinical evaluation of a new anorectic agent in obese adults.一种新型食欲抑制剂在肥胖成年人中的对照临床评估。
Pa Med. 1974 Sep;77(9):46-50.
3
Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.马吲哚、右旋苯丙胺及安慰剂治疗外源性肥胖的双盲临床评价
Curr Ther Res Clin Exp. 1973 Jul;15(7):358-66.
4
Preliminary clinical evaluation of a new appetite suppressant. A double-blind study.一种新型食欲抑制剂的初步临床评估。一项双盲研究。
J Med Soc N J. 1966 Oct;63(10):454-7.
5
A double blind controlled trial of a new anorectic agent AN448.新型食欲抑制剂AN448的双盲对照试验。
N Z Med J. 1975 Jun 25;81(542):546-9.
6
[Therapeutic trial of an anorectic agent using the double blind cross-over technic].
Arzneimittelforschung. 1967 Mar;17(3):336-42.
7
Diethylpropion hydrochloride: an effective appetite suppressant.
Curr Ther Res Clin Exp. 1974 Jan;16(1):40-8.
8
[L-thyroxine propylhexedrine in the treatment of obesity. Crossed double blind study].左旋甲状腺素与丙己君治疗肥胖症。交叉双盲研究
Prensa Med Mex. 1974 May-Jun;39(5-6):298-9.
9
Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.比奥纳米、苯丁胺复方制剂与安慰剂治疗外源性肥胖的疗效、安全性及副作用的双盲比较
Curr Ther Res Clin Exp. 1968 Jul;10(7):323-34.
10
A new anorexiant. Clinical evaluation.一种新型食欲抑制剂。临床评估。
Rocky Mt Med J. 1974 Jan;71(1):41-4.
引用本文的文献
1
Double blind cross-over study of a new appetite suppressant AN 448.新型食欲抑制剂AN 448的双盲交叉研究
Eur J Clin Pharmacol. 1975;8(1):71-4. doi: 10.1007/BF00616417.
2
Anorectic drugs: use in general practice.厌食药：在全科医疗中的应用。
Drugs. 1976;11(5):378-93. doi: 10.2165/00003495-197611050-00002.
Zotero 插件